Identifying, building and investing in exceptional startups

What we do

We identify, build and invest in innovative Nordic startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment.

From startup to exit

We provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

We focus on company creation and building biotech startups in the Nordic region. Novo Seeds aims to develop strong and competitive companies that we finance all the way to a commercial exit.

During 2021, Novo Seeds portfolio companies raised a record DKK 3.6 billion (USD 550 million) from international VCs and led three of the largest Series A financings in Europe.

 

Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.

Søren Møller, Managing Partner, Novo Seeds
  • 36

    current portfolio companies.

  • 2000+

    projects and companies reviewed since 2007.

  • 9

    exits since 2007.

All teams

Meet our team

Novo Seeds is comprised of a team of passionate investment professionals, dedicated to working with scientists and entrepreneurs to build biotech companies in the Nordics.

See our team

Our headquarters

The Novo Seeds team is based at our headquarters in Copenhagen, Denmark.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500
CVR# 24257630